Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Explore wealth management tips tailored to high income individuals, emphasizing diversified investments and efficient tax planning.
26,310 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Investors are hearing a warning bell as markets cling to near-record highs while inflation and geopolitics loom. If a...
Costco reports stronger quarterly results as its $250 billion expansion strategy accelerates, supported by a robust m...
IBM is attracting fresh investor attention as its AI infrastructure strategy gains traction. Arvind Krishna’s reshape...
A 25-year romance culminates in a stylish wedding, offering actionable financial lessons for couples planning celebra...
A large new stake underscores Core Scientific's shift toward data center services. This article breaks down the impli...
Two big catalysts could push XP stock higher: regulatory clarity in Brazil’s fintech scene and stronger cross-selling...
Kaspi.kz faces a pivotal year as it expands its super app, grows its loan book, and navigates regional headwinds. Thi...
When volatility strikes in crypto markets, savvy treasury moves can reshape investor value. This piece examines how a...
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
Daré (DARE) has a developing pipeline and a tight cash runway. This article breaks down what the Q4 2025 earnings cal...
When a major holding shows a sharp fall after earnings, investors scramble for answers. This guide breaks down the re...